Lineage Cell Therapeutics Inc's Comment on Supply Chain
The company depends on suppliers, including sole source manufacturers, but does not currently have long-term supply agreements for key materials used in manufacturing its cell therapy product candidates. It holds a Second Amended and Restated License Agreement with Hadasit, which grants exclusive worldwide rights to certain intellectual property related to human stem cell-derived photoreceptor and retinal pigment epithelial cells for cell therapy in eye disorders. Under this agreement, the company makes payments to Hadasit that include a lump sum, royalties on net sales and sublicensing receipts, annual minimum royalties, and milestone payments linked to clinical trial progress and commercial sales. The agreement has been amended multiple times to update patent listings, research agreements, and payment obligations associated with milestones under a Roche Agreement.
Lineage Cell Therapeutics Inc's Comment on Supply Chain
The company depends on suppliers, including sole source manufacturers, but does not currently have long-term supply agreements for key materials used in manufacturing its cell therapy product candidates. It holds a Second Amended and Restated License Agreement with Hadasit, which grants exclusive worldwide rights to certain intellectual property related to human stem cell-derived photoreceptor and retinal pigment epithelial cells for cell therapy in eye disorders. Under this agreement, the company makes payments to Hadasit that include a lump sum, royalties on net sales and sublicensing receipts, annual minimum royalties, and milestone payments linked to clinical trial progress and commercial sales. The agreement has been amended multiple times to update patent listings, research agreements, and payment obligations associated with milestones under a Roche Agreement.
Sources:
Lineage Cell Therapeutics Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Lineage Cell Therapeutics Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
